{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T07:31:57Z","timestamp":1789543917925,"version":"build-2803163510"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:00:00Z","timestamp":1734739200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.abd.2024.09.004","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T13:08:35Z","timestamp":1737551315000},"page":"215-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Livedoid vasculopathy, calciphylaxis, and Martorell\u2019s hypertensive ulcer: update on ischemic ulcers due to impaired microcirculation of the lower limbs"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8100-5978","authenticated-orcid":false,"given":"Priscila Neri","family":"Lacerda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7883-5986","authenticated-orcid":false,"given":"Lucas Campos","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2325-8701","authenticated-orcid":false,"given":"Izabelle Ferreira da Silva","family":"Mazeto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2596-9294","authenticated-orcid":false,"given":"H\u00e9lio Amante","family":"Miot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0334-2079","authenticated-orcid":false,"given":"Luciana Patricia Fernandes","family":"Abbade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2024.09.004_bib0005","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/028134300448788","article-title":"Wound management for 287 patients with chronic leg ulcers demands 12 full-time nurses. Leg ulcer epidemiology and care in a well-defined population in southern Sweden","volume":"18","author":"\u00d6ien","year":"2000","journal-title":"Scand J Prim Health Care."},{"key":"10.1016\/j.abd.2024.09.004_bib0010","doi-asserted-by":"crossref","DOI":"10.1007\/s10557-023-07516-2","article-title":"Contemporary medical management of peripheral arterial disease","author":"Cook","year":"2023","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.abd.2024.09.004_bib0015","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1159\/000448245","article-title":"Calciphylaxis and martorell hypertensive ischemic leg ulcer: same pattern - one pathophysiology","volume":"232","author":"Hafner","year":"2016","journal-title":"Dermatology"},{"key":"10.1016\/j.abd.2024.09.004_bib0020","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/ijd.16477","article-title":"Clinical analysis of skin lesions in livedoid vasculopathy: a study of 46 Chinese patients","volume":"62","author":"Zhao","year":"2023","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.abd.2024.09.004_bib0025","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/jamadermatol.2017.4374","article-title":"Treatment for livedoid vasculopathy: a systematic review","volume":"154","author":"Micieli","year":"2018","journal-title":"JAMA Dermatology"},{"key":"10.1016\/j.abd.2024.09.004_bib0030","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1111\/jdv.15830","article-title":"Livedoid vasculopathy: how to diagnose and how to treat?","volume":"33","author":"Lipsker","year":"2019","journal-title":"J Eur Acad Dermatology Venereol"},{"key":"10.1016\/j.abd.2024.09.004_bib0035","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/ijd.13997","article-title":"The management of livedoid vasculopathy focused on direct oral anticoagulants (DOACs): four case reports successfully treated with rivaroxaban","volume":"57","author":"Marques","year":"2018","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.abd.2024.09.004_bib0040","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/iwj.13563","article-title":"Livedoid vasculopathy and its association with genetic variants: a systematic review","volume":"18","author":"Gao","year":"2021","journal-title":"Int Wound J"},{"key":"10.1016\/j.abd.2024.09.004_bib0045","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/DAD.0000000000001133","article-title":"Livedoid vasculopathy presenting in a patient with sickle cell disease","volume":"40","author":"Reagin","year":"2018","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.abd.2024.09.004_bib0050","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14810","article-title":"Livedoid vasculopathy in 75 Brazilian patients in a single-center institution: clinical, histopathological and therapy evaluation","volume":"34","author":"Criado","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.abd.2024.09.004_bib0055","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1684\/ejd.2019.3554","article-title":"Livedoid vasculopathy: does hyperhomocysteinaemia play an aetiological role?","volume":"29","author":"Marsch","year":"2019","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.abd.2024.09.004_bib0060","doi-asserted-by":"crossref","first-page":"478","DOI":"10.4103\/0378-6323.183635","article-title":"Livedoid vasculopathy: a review of pathogenesis and principles of management","volume":"82","author":"Vasudevan","year":"2016","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.abd.2024.09.004_bib0065","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/iwj.14004","article-title":"Livedoid vasculopathy and peripheral neuropathy: a retrospective cohort study of 55 Chinese patients and literature review","volume":"20","author":"Gao","year":"2023","journal-title":"Int Wound J"},{"key":"10.1016\/j.abd.2024.09.004_bib0070","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1177\/1358863X221130380","article-title":"Livedoid vasculopathy: a review with focus on terminology and pathogenesis","volume":"27","author":"Eswaran","year":"2022","journal-title":"Vasc Med"},{"key":"10.1016\/j.abd.2024.09.004_bib0075","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jaad.2024.01.083","article-title":"Inflammatory and vaso-occlusive ulcers: part I - clinical presentation and diagnosis","volume":"91","author":"Shakshouk","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2024.09.004_bib0080","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/ced.14464","article-title":"Direct immunofluorescence findings in livedoid vasculopathy: a 10-year study and literature review","volume":"46","author":"Nuttawong","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.abd.2024.09.004_bib0085","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jaad.2023.12.077","article-title":"Inflammatory and vaso-occlusive ulcers: part II - management","volume":"91","author":"Hines","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2024.09.004_bib0090","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jdcr.2017.09.003","article-title":"Ulcerative livedoid vasculopathy responding to clopidogrel","volume":"4","author":"Kunzler","year":"2018","journal-title":"JAAD case reports"},{"key":"10.1016\/j.abd.2024.09.004_bib0095","article-title":"Efficacy of new low-dose oral anticoagulants in recalcitrant livedoid vasculopathy","volume":"24","author":"Furukawa","year":"2017","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.abd.2024.09.004_bib0100","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jdin.2023.10.005","article-title":"Rivaroxaban in the treatment of livedoid vasculopathy: a long-term retrospective study","volume":"14","author":"Deng","year":"2023","journal-title":"JAAD Int"},{"key":"10.1016\/j.abd.2024.09.004_bib0105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jdcr.2022.08.031","article-title":"Botulinum toxin-A: a novel treatment for livedoid vasculopathy","volume":"29","author":"Crotty","year":"2022","journal-title":"JAAD case reports"},{"key":"10.1016\/j.abd.2024.09.004_bib0110","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jaad.2022.06.1188","article-title":"A novel combination (\u201cCHAP\u201d) regimen for management of livedoid vasculopathy in 12 patients","volume":"88","author":"Coromilas","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2024.09.004_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/20406223221097331","article-title":"Efficacy and safety of intravenous immunoglobulin for treating refractory livedoid vasculopathy: a systematic review","volume":"13","author":"Gao","year":"2022","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.abd.2024.09.004_bib0120","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14470","article-title":"Refractory ulcerations associated with livedoid vasculopathy successfully treated with tofacitinib","volume":"33","author":"Jia","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.abd.2024.09.004_bib0125","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15666","article-title":"Efficacy of adalimumab in the treatment of refractory livedoid vasculopathy: case report and literature review","volume":"35","author":"Dong","year":"2022","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.abd.2024.09.004_bib0130","first-page":"e608","article-title":"Refractory livedoid vasculopathy successfully treated with baricitinib","author":"Pe\u00f1uelas Leal","year":"2023","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.abd.2024.09.004_bib0135","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.4103\/jfmpc.jfmpc_588_19","article-title":"Calciphylaxis and its diagnosis: a review","volume":"8","author":"Baby","year":"2019","journal-title":"J Fam Med Prim Care"},{"key":"10.1016\/j.abd.2024.09.004_bib0140","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1590\/2175-8239-jbn-2021-s111","article-title":"Diagnosis and treatment of calciphylaxis in patients with chronic kidney disease","volume":"43","author":"Lucca","year":"2021","journal-title":"Brazilian J Nephrol"},{"key":"10.1016\/j.abd.2024.09.004_bib0145","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/bmj.2.5658.670","article-title":"Calciphylaxis in Man","volume":"2","author":"Rees","year":"1969","journal-title":"Br Med J"},{"key":"10.1016\/j.abd.2024.09.004_bib0150","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/j.ajkd.2015.01.034","article-title":"Calciphylaxis: risk factors, diagnosis, and treatment","volume":"66","author":"Nigwekar","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.abd.2024.09.004_bib0155","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1126\/science.134.3493.1876","article-title":"Cutaneous molt induced by calciphylaxis in the rat","volume":"134","author":"Selye","year":"1961","journal-title":"Science"},{"key":"10.1016\/j.abd.2024.09.004_bib0160","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/01.ASW.0000423442.08531.fb","article-title":"Martorell hypertensive ischemic leg ulcer: an underdiagnosed entity\u00a9","volume":"25","author":"Alavi","year":"2012","journal-title":"Adv Ski Wound Care"},{"key":"10.1016\/j.abd.2024.09.004_bib0165","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1053\/j.ajkd.2022.06.011","article-title":"Calciphylaxis and kidney disease: a review","volume":"81","author":"Gallo","year":"2023","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.abd.2024.09.004_bib0170","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1056\/NEJMra1505292","article-title":"Calciphylaxis","volume":"378","author":"Nigwekar","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.abd.2024.09.004_bib0175","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.ASW.0000554443.14002.13","article-title":"Chang JJ. Calciphylaxis: diagnosis, pathogenesis, and treatment","volume":"32","year":"2019","journal-title":"Adv Ski Wound Care"},{"key":"10.1016\/j.abd.2024.09.004_bib0180","first-page":"126","article-title":"Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry","volume":"32","author":"Brandenburg","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.abd.2024.09.004_bib0185","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/ndt\/gfs466","article-title":"Novel insights into osteogenesis and matrix remodelling associated with calcific uraemic arteriolopathy","volume":"28","author":"Kramann","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.abd.2024.09.004_bib0190","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/jamadermatol.2017.4920","article-title":"Association between hypercoagulable conditions and calciphylaxis in patients with renal disease: a case-control study","volume":"154","author":"Dobry","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.abd.2024.09.004_bib0195","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1590\/abd1806-4841.20132280","article-title":"Calciphylaxis: a rare but potentially fatal event of chronic kidney disease. Case report","volume":"88","author":"Marques","year":"2013","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.abd.2024.09.004_bib0200","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/DAD.0b013e31827c7f5d","article-title":"Cutaneous calciphylaxis: a retrospective histopathologic evaluation","volume":"35","author":"Mochel","year":"2013","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.abd.2024.09.004_bib0205","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.mayocp.2016.06.025","article-title":"Survival, risk factors, and effect of treatment in 101 patients with calciphylaxis","volume":"91","author":"McCarthy","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.abd.2024.09.004_bib0210","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/nep.12433","article-title":"Hyperbaric oxygen in the treatment of calciphylaxis: a case series and literature review","volume":"20","author":"An","year":"2015","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.abd.2024.09.004_bib0215","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/nep.13081","article-title":"Systematic review of sodium thiosulfate in treating calciphylaxis in chronic kidney disease patients","volume":"23","author":"Peng","year":"2018","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.abd.2024.09.004_bib0220","first-page":"231","article-title":"Clinical management of calcific uremic arteriolopathy before and after therapeutic inclusion of bisphosphonates","volume":"83","author":"Torregrosa","year":"2015","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.abd.2024.09.004_bib0225","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1468-3083.2009.03553.x","article-title":"Arteriolosclerotic ulcer of Martorell","volume":"24","author":"Vuerstaek","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.abd.2024.09.004_bib0230","first-page":"323","article-title":"Ulcer of the leg due to arteriolosclerosis and ischemia occurring in the presence of hypertensive disease (hypertensive-ischemic ulcers); a preliminary report","volume":"32","author":"Hines","year":"1947","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.abd.2024.09.004_bib0235","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1111\/jdv.16787","article-title":"Localization-mapping of arteriolosclerotic ulcers of Martorell using two-dimensional computational rendering reveals a predominant location on the mid-lateral lower leg","volume":"35","author":"Weber","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.abd.2024.09.004_bib0240","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/archdermatol.2010.224","article-title":"Martorell hypertensive ischemic leg ulcer: a model of ischemic subcutaneous arteriolosclerosis","volume":"146","author":"Hafner","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.abd.2024.09.004_bib0245","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1001\/archdermatol.2010.213","article-title":"Clinical approach to atypical wounds with a new model for understanding hypertensive ulcers","volume":"146","author":"Shelling","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.abd.2024.09.004_bib0250","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2230.1995.tb02666.x","article-title":"Arterial hypertension causing leg ulcers","volume":"20","author":"Henderson","year":"1995","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.abd.2024.09.004_bib0255","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s11906-009-0033-6","article-title":"The macrocirculation and microcirculation of hypertension","volume":"11","author":"Feihl","year":"2009","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.abd.2024.09.004_bib0260","first-page":"553","article-title":"Occlusive cutaneous vasculopathies as cause of chronic ulcers","volume":"22","author":"Ronicke","year":"2024","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.abd.2024.09.004_bib0265","doi-asserted-by":"crossref","first-page":"797","DOI":"10.12968\/jowc.2023.32.12.797","article-title":"Clinical characteristics of Martorell hypertensive ischaemic leg ulcer","volume":"32","author":"Karppinen","year":"2023","journal-title":"J Wound Care"},{"key":"10.1016\/j.abd.2024.09.004_bib0270","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.ad.2018.06.016","article-title":"Punch grafting for the treatment of Martorell hypertensive ischemic leg ulcer","volume":"110","author":"Guisado Mu\u00f1oz","year":"2019","journal-title":"Actas Dermosifiliogr (Engl Ed)"},{"key":"10.1016\/j.abd.2024.09.004_bib0275","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1111\/bjd.15901","article-title":"Comparison of pyoderma gangrenosum and Martorell hypertensive ischaemic leg ulcer in a Swiss cohort","volume":"178","author":"Kolios","year":"2018","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.abd.2024.09.004_bib0280","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/dermatopathology11010007","article-title":"The histopathology of leg ulcers","volume":"11","author":"Hofmann","year":"2024","journal-title":"Dermatopathol (Basel)"},{"key":"10.1016\/j.abd.2024.09.004_bib0285","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1468-3083.2006.01399.x","article-title":"A retrospective review of 20 hypertensive leg ulcers treated with mesh skin grafts","volume":"20","author":"Dagregorio","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.abd.2024.09.004_bib0290","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/sj.jhh.1001154","article-title":"Martorell\u2019s hypertensive leg ulcer: case report and concise review of the literature","volume":"15","author":"Graves","year":"2001","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.abd.2024.09.004_bib0295","doi-asserted-by":"crossref","first-page":"356","DOI":"10.12968\/jowc.2022.31.4.356","article-title":"Pain control with punch grafting in ulcers with underlying arteriolosclerosis","volume":"31","author":"Quintana-Castanedo","year":"2022","journal-title":"J Wound Care"},{"key":"10.1016\/j.abd.2024.09.004_bib0300","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1001\/archdermatol.2011.84","article-title":"Topical treatment of hypertensive leg ulcers with platelet-derived growth factor-BB: a randomized controlled trial","volume":"147","author":"Senet","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.abd.2024.09.004_bib0305","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/0002-9149(66)90247-5","article-title":"Hypertensive ischemic ulcer. A review of 40 cases","volume":"17","author":"Schnier","year":"1966","journal-title":"Am J Cardiol"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059624002630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059624002630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T15:00:52Z","timestamp":1747666852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365059624002630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0365059624002630"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2024.09.004","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Livedoid vasculopathy, calciphylaxis, and Martorell\u2019s hypertensive ulcer: update on ischemic ulcers due to impaired microcirculation of the lower limbs","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2024.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedade Brasileira de Dermatologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}